Effects of Exercise on the Progression of Multiple Sclerosis by Briggs, Nicole
University of the Pacific 
Scholarly Commons 
Physician's Assistant Program Capstones School of Health Sciences 
4-1-2020 
Effects of Exercise on the Progression of Multiple Sclerosis 
Nicole Briggs 
University of the Pacific, nbriggs1@mail.csuchico.edu 
Follow this and additional works at: https://scholarlycommons.pacific.edu/pa-capstones 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Briggs, Nicole, "Effects of Exercise on the Progression of Multiple Sclerosis" (2020). Physician's Assistant 
Program Capstones. 47. 
https://scholarlycommons.pacific.edu/pa-capstones/47 
This Capstone is brought to you for free and open access by the School of Health Sciences at Scholarly Commons. 
It has been accepted for inclusion in Physician's Assistant Program Capstones by an authorized administrator of 














Final Draft MPAS 218 












Multiple sclerosis (MS) has a vast array of clinical presentations, yet the science of its 
pathophysiology has not evolved adequately to target or prevent the sequelae of the disease. 
What is known, however, is that MS is a chronic inflammatory and neurodegenerative disease of 
the central nervous system due to demyelination of the axons of white matter resulting from 
infiltration of lymphocytes and astrocytes. 1 This axonal loss leads to the neurologic and 
constitutional (or systemic) deficits: visual disturbances, tremors, weakness, fatigue, cognitive 
impairment, depression/anxiety, poor motor control, and overall very poor quality of life from 
reduced mobility. 2 The associated inflammation and degeneration is hypothesized to be caused 
by high imbalance of cytokine activity and disturbances in the blood-brain-barrier (BBB). 3 This 
pathophysiologic process causing high levels of inflammation, eventually leads to scarring of the 
neurons, producing plaques on brain MRI (magnetic resonance imaging), which assists in 
diagnosing MS. All these harmful sequelae are not only debilitating, but also significantly 
increase the risk of developing comorbidities in addition to direct neurologic damages. This 
progressive destruction of the CNS promotes a vicious cycle resulting in negative health effects. 
The disease and its severity vary substantially among individuals. This disparity is partly 
due to the different subsets of multiple sclerosis. MS is divided into relapsing-remitting, 
secondary progressive, primary progressive, and progressive relapsing. This variability in MS 
leads to difficulties channeling treatment modalities that help all individuals. Relapsing-remitting 
MS (RRMS) is a main focus of research to date because it is one of the few subtypes that has 
pharmacologic treatments (including corticosteroids and other biologic medications) which 
target the relapse phase. However, pharmacologic therapy poses other difficulties because not all 
medications have been shown to be beneficial and each has its own risks. Besides pharmacologic 
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treatments, other therapies are being sought for the treatment of symptoms and disease 
progression. Not all have been successful. So, apart from pharmacotherapy, what other therapies 
are effective for the prevention and/or mitigation of symptoms and disease progression in MS? 
Recent research is revisiting exercise as a treatment modality. In healthy persons it decreases 
inflammation and works similarly in patients with MS while also decreasing all the negative side 
effects of inflammation and neurodegeneration. Nevertheless, MS patients have long been 
advised to refrain from physical exercise. The advice stemmed from the misconception that 
symptoms tended to transiently worsen when the body temperature increased. 4 These apparent 
conflicting findings underlie the need to explore how aerobic/anaerobic exercise compared to 
sedentary lifestyles influence the quality of life and progression of MS over an individual’s life 
span. 
Indeed, physical exercise may be proven beneficial for MS patients. Moreover, exercise 
has other health benefits. Hence, it could become a highly recommended treatment that would 
deserve a high priority among therapeutic options. Many patients with MS are not informed 
about adjunctive treatment options such as exercise for reducing disease severity and 
progression.    
Discussion 
The evidence thus far, has confirmed that exercise has a surplus of benefits for patients 
suffering from MS. Overall the most consistent findings have been improvements in gait, fatigue, 
cognition and cardiopulmonary function. 5 , 6  In the randomized control trial by Giancario et. al, 
evaluating fatigue and cognitive function with aerobic and anaerobic training. There were 
significant improvements in motor function, cognition, cardiopulmonary function, and decreased 
fatigue. Although these findings are slightly limited by the small sample size. Benefits from 
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exercise have been shown to be independent of an individual’s weight or baseline physical 
capacities before exercise routines began. 7 These findings were evidenced by a single 
randomized control trial by Negaresh et al, evaluating depression, fatigue, cognition in an 8-
week aerobic training program, with regards to baseline weight status. These benefits 
notwithstanding some of the most debilitating factors in patients with MS, other than physical 
impairments, are the reduction in cognition and the persistent fatigue. 1 The diminished cognitive 
faculty can be a severe burden when patients attempt to accomplish everyday tasks. 6 Fifty 
percent of patients with MS experience fatigue at least once a week, which is chiefly due to the 
disease process, but also partly due to the pharmacologic treatments that are commonly 
prescribed. 7 As the disease progresses and the older the individuals are, the worse both cognitive 
decline and fatigue become. 6 The declines are what prompted a systematic review of clinical 
trials by Sokolov et al, comparing different interventions and their impact on fatigue and 
cognition. Exercise, especially in a multimodal approach, was shown to be superior to 
pharmacologic therapy to mitigate those symptoms. Further advancements in technology will be 
able to solidify this evidence further by evaluating cognition more in depth. Data from testing the 
effects of exercise on cognition have been promising. Learning/memory as assessed by specific 
cognition tests (viscoelasticity of brain tissue in the hippocampus as measured by magnetic 
resonance elastography or MRE) and fatigue levels as determined by VO2 all showed significant 
improvements in a pilot study by Sandroff et al, after a 12-week aerobic exercise program guided 
by ACSM. 8 This study has the limitation of technology for more insight into the changes that 
occur. Fatigue has also been shown to decrease when assessed using the fatigue severity scale 
after exercise, in a blind randomized control trial by Negaresh et al. Measurements of fatigue 
were done after completing as little as an 8-week interval training program of exercise 3 days a 
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week. There were significant improvements in mood, fatigue, motor performance.  7 These 
findings are independent of weight status prior to the trial, however, a longer duration study 
would be needed to strengthen the evidence. With this short duration of exercise producing such 
favorable results, it would be interesting to investigate how much improvement could be derived 
from exercise over a longer period of time.  
In addition to memory and fatigue, other indicators of disease remission and progression 
provide insight about the benefits of exercise. Pathophysiologic markers associated with MS, 
including imbalances in neurotrophic factors, and levels of BBB markers that reflect disease 
severity, are useful tools for this purpose. In a recent systematic review by Negaresh et al, 
reviewing effects of exercise on pathophysiological biomarkers in MS individuals indicate 
exercise can reduce said markers, improve brain function and integrity, provide a neuroprotective 
effect, and significantly reduce inflammatory markers. 9.Due to inclusion criteria, it’s difficult to 
find a substantial number of studies that qualify. More studies are needed to validate the 
information further. Inflammation in MS is known to be partly due to higher cytokine levels. 
Exercise has been shown to mildly lower leptin and TNF (tumor necrosis factor) levels, which 
are increased in patients (or persons) with chronic inflammation from any disease state. This was 
shown in a randomized control trial by Majdinasab et al, investigating response of various 
cytokines and adipokines in response to acute aerobic exercise, with levels being examined at 
hour 1 and hour 6 post exercise. Limitations of the study include cytokine measurements only 
taken from serum as well as the timing of the sample measurements. These findings indicate that 
exercise can act as an anti-inflammatory agent, thus achieving one of the main goals of treatment 
in MS patients. 3 
 6 
 Another malady due to MS is poor respiratory health, which. has been shown to 
contribute to sedentary behavior and can discourage MS patients from participating in physical 
activity. Respiratory muscles improve with exercise as well, which then improves fatigue and 
overall quality of life. This statistically significant finding was revealed in a quasi-experimental 
study evaluating respiratory strength, fatigue, quality of life, and functional performance after a 
five-week training program of combined progressive resistance respiratory muscle therapy. 10 
Although individual’s baseline differences were variable in this study, these findings are 
favorable. 
All these findings mentioned thus far, were from studies that focused on combined 
exercise training programs or just mild aerobic activity. Since then, significant findings emerged 
from studies that evaluated aerobic and anaerobic exercise separately. Results from evaluating 
each type of exercise separately indicated the importance of incorporating a mixed exercise 
program. Different effects are produced by aerobic and anaerobic exercises. Aerobic activity has 
been shown to improve the immune system as evidenced by evaluation of T-cell changes 
(increases CD39 cells and decrease in their counterparts CD31 cells) in a controlled, single blind, 
randomized control trial by Mahler et al. Thus, improving the immune system in an 
immunocompromised person.11 Anaerobic workouts improve energy metabolism by increasing 
fatty acid oxidation.11 Significant improvements in depression and cholesterol levels from both 
anaerobic and aerobic training were also found in evaluating individuals under hypoxic 
conditions. Thus, the effects of exercise help fight against acute health problems while also 
preventing chronic comorbidities. Again, duration of study is a limitation but findings are 
consistent with exercise improving many aspects of these patients’ lives overall.  
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Lastly, data reflecting neuroprotection were found with activities such as walking and 
running on the treadmill. In a 2016 randomized control study investigating aerobic exercise and 
its neuroprotective capabilities, the findings indicate these exercise modalities increase brain-
derived neurotrophic factor (BDNF) levels. Because BDNF serves as a neuroprotective 
mechanism, increasing or maintaining its level is crucial for preventing the progression of MS. 
The increase in cytokines associated with MS already decreases BDNF significantly. BDNF 
levels increased about 10% after a 24-week exercise intervention program compared to the group 
that was sedentary.12 This same study also measured results from combined resistance and 
endurance training, showing improvements in muscle strength and mobility. Individuals were 
much more capable and stable in just performing walking tests.12 Improvements in mobility and 
strength indicated that not only is exercise safe for patients with MS, but also that being 
sedentary can actually speed up the disease process and contribute to the inflammation and 
degeneration.  
Among the experimental and systematic reviews, studies on mice are available. These 
experiments, while not as convincing as human studies, still indicate promising results. One 
evaluated mice with autoimmune encephalitis. This disease process is similar to the infiltration 
and demyelination associated with MS. Exercise was shown to delay the disease onset and the 
rise in disability scores in mice who exercised compared with mice that were sedentary as 
evidenced by observation of their behavior or physical condition and by evaluation their white 
and gray matter. 1 
Summary 
Overall, the evidence to date indicates that exercise mitigates the manifestations of 
multiple sclerosis, not only by reducing symptoms but also by harnessing a neuroprotective 
 8 
effect, which attenuates the neurodegeneration. This conclusion has been derived from 
experimental studies and systematic reviews that incorporated various means of measuring 
cognitive and physiologic benefits, including imaging, blood samples and multiple 
surveys/exams. Because MS is not completely understood at the cellular level, the studies 
themselves have not been able to target everything at the cellular level. Research on the effects 
of exercise on MS is ongoing and additional results should provide further insight. Nonetheless, 
MS is a very intricate and complex disease process. It will take time to further understand how 
and what specific exercise modalities will prove to be the most beneficial and provide the most 
neuroprotection. Many of these studies had some limitations, the most common one being small 
sample sizes. Another weakness was the short duration of follow up. It’s very difficult to enroll 
large sample sizes and to monitor participants for long periods of time. Furthermore, many of the 
studies examined RRMS patients and did not evaluate the other subsets of MS, thus limiting the 
generalizability of the findings. These limitations notwithstanding, all studies had similar 
exercise modalities, such as treadmill walking/running and upper/lower body cycling, which was 
a strength.  
In view of the limited evidence, further investigation is needed to confirm the 
neuroprotective effects and the reductions in the overall negative effects of MS with increased 
understanding of the disease pathophysiology at a cellular level. Long term studies are needed as 
well to evaluate reduction in the disease progression and severity. Larger sample sizes and 
sampling from different subsets of MS patients will be needed as well to increase the validity and 
generalization of the results. Some studies even suggested using a broader version of initial 
disability scales that range from mildly disabled and severely disabled in order to measure the 
varying effect from exercise.3 
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Conclusion 
 Aerobic and anaerobic exercise, both providing different benefits, are crucial for optimal 
care of MS patients and should be part of the practitioner’s treatment plan. Many patients with 
MS are left without many options. If exercise is implemented early in the disease, the patient’s 
quality of life can improve and associated debility can be minimized. Exercise prescriptions can 
be initiated by providing referrals for supervised physical activity after determining the patient’s 
baseline limitations, which vary from individual to individual. Many studies have already been 
initiated to further investigate all of the current findings and affirm the importance of exercise as 
a treatment tool. Unless an individual has a specific contraindication to exercise, some form of 

































Figure A: Shows the ventral region of the lumbar spinal cord in mice comparing exercise vs. sedentary 
behavior. Figure B: Shows ventral white matter tracts. Figure C: indicates the amount of infiltration in exercise 
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